iVigee hosted a conversation with Henry Seto discussing AI taking over daily pharmacovigilance work and supervising it.
Public source
Publisher name
Public post
I sat down with Henry Seto to talk about what happens when AI takes over the daily pharmacovigilance work: the job shifts from doing it to supervising it, and that only…
Company
iVigee
- Industry
- Biotechnology Research
- Location
- Burlington, US
- Company size
- 51–200 employees
About iVigee
iVigee delivers physician-led pharmacovigilance grounded in truth. You receive pharmacovigilance services and consulting across the entire product lifecycle, from clinical development through post-marketing authorization. Our approach is built on transparency, regulatory realism, and straight answers you can trust, so you’re never left guessing. You work with physicians, former regulators, EU QPPVs, and senior safety leaders who understand how pharmacovigilance is evaluated in real inspections. We focus on what regulators actually look for, what they question, and what they expect you to explain, not just what guidance says. We support you as you build, optimize, and transform your pharmacovigilance capabilities, providing clarity at every stage, from early system design through mature, inspection-ready operations. Across everything we do, you always know where you stand, before inspections, before submissions, and before issues become findings. iVigee operates under an ISO 9001: 2015 – certified quality management system, ensuring the way we work is as structured, consistent, and accountable as the systems we help you establish and maintain.
See moreLatest activity
Latest activity from iVigee
13 signals
Presence & Recognition
iVigee hosted a conversation between Henry Seto and Jan Petracek discussing how AI is changing pharmacovigilance work and supervising it.
Research & Knowledge
iVigee published the Netherlands policy on risk minimization measures
Research & Knowledge
iVigee published the Chinese translation of ICH E2D(R1) for consultation in China
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
PrimeVigilance
PrimeVigilance is hosting a DIA webinar exploring how advancing AI regulations are shaping the future of pharmacovigilance and what QPPVs need to consider as technology becomes a greater part of the PV operating model
Presence & Recognition
Genentech
Genentech participated in the BIO 2026 conference to discuss how AI is helping shape the future of biotechnology.
Presence & Recognition
DrugCard
DrugCard released the recording of a webinar featuring Dmytro Horilyk and Jan Kolouch following a demo.
Presence & Recognition
Roche
Roche is hosting a discussion on AI in Switzerland on November 18 and 19.
Presence & Recognition
Insilico Medicine